NCT04208529: A Long-term Follow-up Study in Participants Who Received CTX001
- State
- Under way
- Phase
- Phase 3
- People
- 160 planned
- Started
- 20 Jan 2021
- Primary completion
- 30 Sep 2039
- Arms
- CTX001
- Results
- None posted
- Papers
- doi:10.1002/ajh.70382, doi:10.1182/bloodadvances.2025016701, doi:10.1182/bloodadvances.2025016702
- 23 Dec 2019: Trial registered
- 20 Jan 2021: Trial started